Psilocybin and Psychedelics in Utah: Pending Legislation
This page tracks the current legal status of psilocybin, psychedelics, and entheogens in Utah. Status is updated from our legislation sync, with citations to the underlying bills and policy decisions.
Utah passed SB 266 unanimously, permitting Intermountain Health and University of Utah Health to develop behavioral health treatment programs using psilocybin and MDMA. Sponsored by Sen. Kirk Cullimore (R), this represents a conservative-state approach focused on clinical research within established healthcare institutions.
SB 266 passed Utah legislature unanimously Sponsored by Sen. Kirk Cullimore (R) Permits Intermountain Health and University of Utah Health to develop psilocybin/MDMA treatment programs Focus on behavioral health treatment within established medical institutions Conservative-state model: clinical research, not recreational access Builds on previous HB 167 (2022) groundwork
Laws change. Always verify current status with primary sources before acting on this information, especially when traveling across state lines.